AdaptHealth Corp. (AHCO) — Fair Value Analysis
Base-case fair value (P50): $15.70 · Current price: $9.94 · Verdict: Undervalued
The Verdict on AHCO
ADAPTHEALTH CORP (AHCO) appears deeply undervalued according to our Monte Carlo simulation analysis. Currently trading at $9.94, the median fair value (P50) for AHCO is calculated to be $15.70. This suggests a significant potential +58.0% from the current market price, indicating a substantial discrepancy between AHCO's present valuation and its intrinsic worth as projected by thousands of forward-looking scenarios. Our analysis firmly points to AHCO presenting a compelling valuation opportunity for investors seeking exposure within the Healthcare sector, despite its current market price.
How AHCO stacks up against Healthcare
While AHCO's operational and financial health is categorized as average when compared to its Healthcare sector peers, this assessment highlights underlying stability that supports its attractive valuation. The substantial +58.0% potential relative to the median fair value of $15.70, compared to its $9.94, suggests that the market may not be fully appreciating AHCO's fundamental value, even with an average quality tier. Investors typically seek such opportunities where a solid, if not exceptional, quality profile combines with a significant valuation gap. This blend positions AHCO as a potentially undervalued asset within its sector.
What this means for investors
The pronounced +58.0% from AHCO's $9.94 to its $15.70 fair value, as derived from our Monte Carlo simulations, indicates a strong positive skew in potential returns. While an average quality tier suggests diligence is warranted, the "Deeply Undervalued" verdict points to a significant margin of safety and potential for price appreciation. For those considering an entry point into the Healthcare sector, AHCO's current valuation merits close attention. Explore the full bear and bull distribution, and track AHCO's fair value as new fundamentals are released, by signing up for a free FairCurve account.
Frequently Asked Questions
Is AHCO overvalued or undervalued right now?
Based on our Monte Carlo simulations, ADAPTHEALTH CORP (AHCO) is currently considered deeply undervalued. Its current price of $9.94 is significantly below its median fair value of $15.70.
What is the bear case and bull case for AHCO?
The full Monte Carlo distribution, including bear (P10) and bull (P90) price targets, as well as the probability of achieving upside, is exclusively available to users with a free FairCurve account.
How does FairCurve calculate AHCO's fair value?
FairCurve calculates AHCO's fair value using advanced Monte Carlo simulations, running thousands of forward scenarios to determine a probabilistic range of potential intrinsic values.
How can I track AHCO's fair value as it changes?
You can add AHCO to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings or financial data are released.